In line with the OS analysis, we could show that a high liver fibrosis score is, indeed, associated with a shorter PFS in patients with iCCA receiving gemcitabine-based chemotherapy, although these results did not reach statistical significance ( p = 0.145).
← all excerpts
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy.
1
0.1450
0.1450